Physician profile
Christopher Morande
NPI 1730856121
$495.33
in general payments reported to CMS, 2019-2025
9 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $250 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $250.00 | 2023 | Xarelto |
| Lilly USA, LLC | $50.06 | 2025 | Zepbound, Mounjaro |
| Medicomp INC | $45.28 | 2025 | Telepatch Cardiac Monitor |
| Vertex Pharmaceuticals Incorporated | $29.91 | 2025 | |
| Optinose US, INC. | $29.40 | 2025 | |
| Tactile Systems Technology INC | $26.75 | 2025 | Nimbl, Flexitouch Plus |
| Novo Nordisk INC | $25.28 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.38 | 2025 | Airsupra |
| Philips North America LLC | $17.27 | 2025 | Mcot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Morande listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.